CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion.
about
CCR9 in cancer: oncogenic role and therapeutic targetingThe role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinomaChemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin.The role of chemokines in breast cancer pathology and its possible use as therapeutic targetsAntitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and DysfunctionParacrine Activation of Chemokine Receptor CCR9 Enhances The Invasiveness of Pancreatic Cancer CellsTwist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway.CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.Nuclear pattern of CXCR4 expression is associated with a better overall survival in patients with gastric cancer.Protective effects of ADAM8 against cisplatin-mediated apoptosis in non-small-cell lung cancer.
P2860
Q28066712-7B2C19A4-E84D-40D6-8A45-2D0500A9A62CQ28477884-95354A62-2B96-4B28-AB5B-0441E425D287Q30358552-C70D1D68-8F2C-4D7A-B14E-9D6F03685466Q33845577-5C0C5116-434A-48B9-9521-DBE51792F809Q34069862-14D10DE2-024F-47DB-9B6E-B36C8894822BQ34223860-F00D567E-9C98-441A-A540-B919D6EB0790Q35848297-8778A091-CEF6-4AC8-AD00-85B4B0E068A6Q36956778-D12F414F-6F85-43D2-A406-65B7C494ED9EQ37373813-CAD4D1B8-3C9E-4504-B5FA-B91C70FC6832Q37652592-DBD2C6A6-72DB-4FE5-9E0D-27D295A8C685Q38908550-C1155B54-D497-4C9E-ABC2-99B794AF6ADDQ39012611-AEC8B16B-29CB-41D0-8F1C-90267F17E1ABQ39210507-AB7757C6-B245-4FA0-9FB3-CCDDBB7F7088
P2860
CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CCR9-CCL25 interactions promot ...... t and FAK-independent fashion.
@ast
CCR9-CCL25 interactions promot ...... t and FAK-independent fashion.
@en
type
label
CCR9-CCL25 interactions promot ...... t and FAK-independent fashion.
@ast
CCR9-CCL25 interactions promot ...... t and FAK-independent fashion.
@en
prefLabel
CCR9-CCL25 interactions promot ...... t and FAK-independent fashion.
@ast
CCR9-CCL25 interactions promot ...... t and FAK-independent fashion.
@en
P2093
P2860
P356
P1476
CCR9-CCL25 interactions promot ...... t and FAK-independent fashion.
@en
P2093
Crystal Johnson-Holiday
Erica L Johnson
James W Lillard
Rajesh Singh
Shailesh Singh
William E Grizzle
P2860
P2888
P356
10.1186/1477-7819-9-46
P577
2011-05-03T00:00:00Z
P5875
P6179
1033265983